×
Chemed Cash on Hand 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed cash on hand for the quarter ending September 30, 2024 was
$0.238B
, a
37.71% increase
year-over-year.
Chemed cash on hand for 2023 was
$0.264B
, a
256.09% increase
from 2022.
Chemed cash on hand for 2022 was
$0.074B
, a
125.34% increase
from 2021.
Chemed cash on hand for 2021 was
$0.033B
, a
79.78% decline
from 2020.
View More
Chemed Cash on Hand 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed cash on hand for 2023 was
$0.264B
, a
256.09% increase
from 2022.
Chemed cash on hand for 2022 was
$0.074B
, a
125.34% increase
from 2021.
Chemed cash on hand for 2021 was
$0.033B
, a
79.78% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$19.5B
Quest Diagnostics (DGX)
$18B
DaVita (DVA)
$12.9B
Encompass Health (EHC)
$10B
Elanco Animal Health (ELAN)
$6.6B
RadNet (RDNT)
$5.9B
Option Care Health (OPCH)
$3.7B
Amedisys (AMED)
$2.9B
LifeStance Health (LFST)
$2.8B
Astrana Health (ASTH)
$2.3B
Addus HomeCare (ADUS)
$2.2B
U.S Physical Therapy (USPH)
$1.4B
Aveanna Healthcare Holdings (AVAH)
$1.1B
Pennant (PNTG)
$1.1B
Atai Life Sciences (ATAI)
$290M
Daxor (DXR)
$43M
MEDIROM Healthcare Technologies (MRM)
$15M
Psychemedics (PMD)
$14M
ATI Physical Therapy (ATIP)
$8M
Ontrak (OTRK)
$8M
IMAC Holdings (BACK)
$1M